Aug 09, 2023 5:30pm EDT

Medexus Announces Strong Fiscal Q1 2024 Results, Including Record Quarterly Revenue of US$31.6 Million

Aug 04, 2023 7:00am EDT

Medexus to Participate in Fireside Chat at SHARE Series Event

Aug 02, 2023 7:00am EDT

Medexus Schedules First Fiscal Quarter 2024 Conference Call

Jul 12, 2023 5:30pm EDT

Medexus Announces Preliminary Revenue for Fiscal Q1 2024

Jun 21, 2023 5:40pm EDT

Medexus Generates Record Revenue of Us$108.1 Million in Fiscal Year 2023

Jun 15, 2023 7:25am EDT

FDA Accepts for Review Medexus's IXINITY Supplemental Biological License Application for Pediatric Patients

Jun 14, 2023 5:30pm EDT

Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2023 Conference Call

Jun 13, 2023 7:25am EDT

Medexus Highlights Data on Trecondyv (Treosulfan) Presented at MDS 2023

Jun 01, 2023 5:30pm EDT

Medexus to Participate in the LD Micro Invitational XIII

May 10, 2023 5:30pm EDT

Medexus Announces Normal Course Issuer Bid, or NCIB, for Its Convertible Debentures